Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet

Journal of Nutritional Biochemistry

Volumn 21, Issue 4, 2010, Pages 261-267

  Mutungi, Gisella ^a   Waters, David ^a   Ratliff, Joseph ^a   Puglisi, Michael ^a   Clark, Richard M ^a   Volek, Jeff S ^a   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adult men; Apolipoproteins; Carbohydrate restriction; Carotenoids; Eggs; Lipoprotein subclasses; Weight loss

Indexed keywords

ALPHA CAROTENE; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYCOPENE; VERY LOW DENSITY LIPOPROTEIN; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; EGG YOLK; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; LOW CARBOHYDRATE DIET; MALE; MOLECULAR SIZE; PROTEIN LOCALIZATION; VITAMIN BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS; BODY MASS INDEX; CAROTENOIDS; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; DIET, CARBOHYDRATE-RESTRICTED; DIET, REDUCING; EGGS; FOOD, FORMULATED; HUMANS; LIPOPROTEINS; LUTEIN; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; TRIGLYCERIDES; WEIGHT LOSS; XANTHOPHYLLS;

EID: 77649272694     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.12.011     Document Type: Article

References (35)

1. Expert Panel on Detection EaToHBCiA. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 285 (2001) 2486-2497
2. Yuan G., Al-Shali K.Z., and Hegele R.A. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 176 (2007) 1113-1120
3. Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., and Rimm E.B. Non-high-density lipoprotein cholesterol and apolipoprotein b in the prediction of coronary heart disease in men. Circulation 112 (2005) 3375-3383
4. Zambon A., Bertocco S., Virtturi N., Polentarutti V., Vianello D., and Crepaldi G. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans 31 (2003) 1070-1074
5. Tornvall P., Karpe F., Carlson L.A., and Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 90 (1991) 67-80
6. Tribble D.L., Holl L.G., Wood P.D., and Krauss R.M. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93 (1992) 189-199
7. Johansson J., Carlson L.A., Landou C., and Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11 (1991) 174-182
8. Marcovina S., and Packard C.J. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Int Med 259 (2006) 437-446
9. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarctin in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
10. Meisinger C., Loewel H., Mraz W., and Koenig W. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J 26 (2005) 271-278
11. Lamarche B., Moorjani S., Lupien P.J., Cantin B., Bernard P., Dagenais G., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 94 (1996) 273-278
12. Onat A., Ozhan H., Can G., Hergenc G., Karabulut A., and Albayrak S. Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks. Anadolu Kardiyol Derg 7 (2007) 128-133
13. Clark R.M., Herron K.L., Waters D., and Fernandez M.L. Hypo- and hyper-response to egg cholesterol predicts lutein and beta-carotene plasma concentrations in men and women. J Nutr 136 (2006) 601-607
14. Furr H.C., and Clark R.M. Intestinal absorption and tissue distribution of carotenoids. Nutr Biochem 8 (1997) 364-377
15. Landrum J.T., and Bone R.A. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385 (2001) 28-40
16. Mutungi G., Ratliff J., Puglisi M., Torres-Gonzalez M., Vaishnav U., Leite J.O., et al. Dietary cholesterol from eggs increases HDL cholesterol in overweight men consuming a carbohydrate restricted diet. J Nutr 138 (2008) 272-276
17. Wood R.J., Volek J.S., Liu Y., Shachter N.S., Contois J.H., and Fernandez M.L. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL and HDL subfraction distribution and size in overweight men. J Nutr 136 (2006) 384-389
18. Liu M.Y., Xydakis A.M., Hoogeveen R.C., Jones P.H., Smith E.O., Nelson K.W., et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem 51 (2005) 1102-1109
19. Ogawa Y., and Fielding C.J. Assay of cholesteryl ester transfer activity and purification of a cholesteryl ester transfer protein. Methods Enzymol 111 (1985) 274-285
20. Hospattakar A.V., Fairwell T., Ronan R., and Brewer H.B. Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. J Biol Chem 259 (1984) 318-322
21. Adiels M., Taskinen M.R., Packard C., Caslake M.J., Soro-Paavonen A., Westerbacka J., et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49 (2006) 755-765
22. Hiukka A., Fruchart-Najib J., Leinonen E., Hilden H., Fruchart J.C., and Taskinen M.R. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in Type 2 diabetes. Diabetologia 48 (2005) 1207-1215
23. Laws A., Hoen H.M., Selby J.V., Saad M.F., Haffner S.M., and Howard B. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status: relation to plasma triglyceride and apolipoprotein B concentration. Insulin Atherosclerosis Study (IRAS) investigators. Arterioscler Thromb Vasc Biol 17 (1997) 64-71
24. Seshadri P., Iqbal N., Stern L., Williams M., Chicano K.L., Daily D.A., et al. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med 117 (2004) 398-405
25. Westman E.C., Yancy Jr. W.S., Olsen M.K., Dudley T., and Guyton J.R. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol 110 (2006) 212-216
26. Krauss R.M., Blanche P.J., Rawlings R.S., Fernstrom H.S., and Williams P.T. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr 83 (2006) 1025-1031
27. Feinman R., and Volek J. Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss. Nutr Met (Lond) 3 (2006) 24
28. Herron K.L., Lofgren I.E., Sharma M., Volek J.S., and Fernandez M.L. A high intake of dietary cholesterol does not result in more atherogenic LDL particles in men and women independent of response classification. Metab Clin Exp 53 (2004) 823-830
29. Greene C.M., Waters D., Clark R.M., Contois J.H., and Fernandez M.L. Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr Met 3 (2006) 6
30. Tailleux A., Duriez P., Fruchart J.C., and Clavey V. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 164 (2002) 1-3
31. Jahn C.E., Osborne J.C., Schaefer E.J., and Brewer H.B. In vitro activation of the enzymic activity of hepatic lipase by apo A-II. FEBS Lett 131 (1981) 366-368
32. Castenmiller J.J.M., West C.E., Linssen J.P.H., van het Hof K.H., and Voragen A.G.J. The food matrix of spinach is a limiting factor in determining the bioavailability of β-carotene and to a lesser extent of lutein in humans. J Nutr 129 (1999) 349-355
33. Voutilainen S., Nurmi T., Mursu J., and Rissanen T.H. Carotenoids and cardiovascular health. Am J Clin Nutr 83 (2006) 1265-1271
34. Richer S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75 (2004) 216-230
35. Erdman J.J., Bierer T., and Gugger E. Absorption and transport of carotenoids. In: Canfield L., Krinsky N., and Olson J. (Eds). Carotenoids in Human Health (1993), NY Acad. Sci., New York 76-86